That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.
Palferman
T G
TG
Department of Rheumatology, Yeovil District Hospital, Somerset, United Kingdom.
D015519:Bone Density; D000075202:Contraindications; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D045167:Progesterone Congeners / Q000627:therapeutic use
D004967:Estrogens; D045167:Progesterone Congeners